EXPLEO SOLUTIONS LIMITED Fair Value
EXPLEOSOL · Information Technology · Current price ₹883.8
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹711 | 19% ROE fading to 12% over ~20 yrs, on ₹500 book |
| Relative P/E | ₹1,737 | EPS × 21.7 peer-median P/E |
| Graham floor | ₹948 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹1,140 | Street consensus 12-month target price |
Is EXPLEO SOLUTIONS LIMITED undervalued?
DocStoX estimates the fair value of EXPLEO SOLUTIONS LIMITED at ₹1,055 per share, versus the current market price of ₹884. That puts the stock about +19.4% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹711), Relative P/E (₹1,737), Graham floor (₹948), Analyst target (₹1,140). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹711 (bear) to ₹1,055 (base) to ₹1,737 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on EXPLEO SOLUTIONS LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.